Data Bridge Market research has a newly released expansive study titled “Seborrheic Dermatitis Market” which guarantees you will remain better informed than your competition. This study provides a broader perspective of the marketplace with its comprehensive market insights and analysis which eases surviving and success in the market.
Market Analysis and Size
In recent years, the seborrheic dermatitis market is anticipated to proliferate during the forecast period. In the United States and worldwide, seborrheic dermatitis is a prevalent dermatological condition. Immunocompromised patients, such as HIV patients, lymphoma patients, and organ transplant recipients, are more likely to develop seborrheic dermatitis. Dandruff is a minor variant of seborrheic dermatitis. Compared to seborrheic dermatitis, dandruff is far more widespread, affecting almost half of the global adult population. According to the National Center for Biotechnology Information, dandruff prevalence was 81–95 percent in African Americans, 66–82 percent in Caucasians, and 30–42 percent in Chinese in a research conducted in the United States and China.
Data Bridge Market Research analyses that the seborrheic dermatitis market was valued at USD 2.16 billion in 2021 and is expected to reach USD 4.98 billion by 2029, registering a CAGR of 11.00% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
The skin illness seborrheic dermatitis develops an itchy rash with flaky scales. On light skin, it causes redness, and on darker skin, it causes light patches. Dandruff, cradle cap, seborrhea, seborrheic eczema, and seborrheic psoriasis are some of the other names for it. It may resemble psoriasis, eczema, or an allergic reaction in appearance. Seborrheic dermatitis is more common in newborns and adults aged 30 to 60. It's more frequent in men than in women, and it's more common in persons who have oily skin.
View Detailed Report@ https://www.databridgemarketresearch.com/reports/global-seborrheic-dermatitis-market
Some of the major players operating in the seborrheic dermatitis market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Eli Lilly and Company (US)
- Merck & Co., Inc. (US)
- Allergan (Ireland)
- AstraZeneca (UK)
- AbbVie Inc. (US)
- Johnson & Johnson Private Limited (US)
- Cipla Inc. (US)
- Abbott (US)
- Merck KGaA (Germany)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Hikma Pharmaceuticals PLC (UK)
- LEO Pharma A/S (Denmark)
- Bausch Health Companies Inc. (Canada)
- Monarch Pharmachem (US)
- Baxter (US)
Drivers
- Increasing prevalence of dermatological diseases
The rising prevalence of dermatological diseases is estimated to enhance the seborrheic dermatitis market's growth. Eczema, psoriasis and tinea versicolor are the various skin diseases that increase the risk of seborrheic dermatitis, further propelling the market's growth rate.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of the seborrheic dermatitis market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
- Growing number of geriatric population
The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to get seborrheic dermatitis, further estimated to enhance the market's growth rate.
Recent Development
- In July 2021, Arcutis Biotherapeutics, Inc. had announced the enrollment of first patient in its single pivotal Phase 3 clinical trial estimating topical roflumilast foam (ARQ-154) as a main treatment for seborrheic dermatitis. The Company is developing Roflumilast foam, a once-daily topical foam formulation of roflumilast, a highly powerful and selective phosphodiesterase type 4 (PDE4) inhibitor, for seborrheic dermatitis.
To achieve noteworthy business growth and maximum return on investment (ROI), adopting supreme this market research report is truly beneficial. The report comprises of most-detailed market segmentation, systematic analysis of major market players, trends in consumer and supply chain dynamics, and insights about new geographical markets. This market report has been framed by taking into account several factors of the present and upcoming market scenario. Statistical and numerical data covered in the report is represented using graphs and tables which simplify the understanding of facts and figures.
The analysis and estimations carried out via this market analysis report helps to get the details about the product launches, future products, joint ventures, marketing strategy, developments, mergers and acquisitions and effect of the same on sales, marketing, promotions, revenue, import, export, and CAGR values. The report assists in determining and optimizing each stage in the lifecycle of industrial process that includes engagement, acquisition, retention, and monetization. An international this market report contains most recent and efficient market insights with which businesses can ponder to augment their marketing, advertising, promotional and sales strategies.
Core Objective of the This Market:
- This Market Size and growth rate factors.
- Important changes in the future this Market.
- Top worldwide competitors of the Market.
- Scope and product outlook of This Market.
- Developing regions with potential growth in the future.
- Tough Challenges and risk faced in Market.
- Global top manufacturers profile and sales statistics.
Browse More Reports:
Global Bovine Ephemeral Fever Vaccines Market
Global Non-Thermal Pasteurization in Dairy Industry Market
Global Gallbladder Cancer Treatment Market
Global Leiomyosarcoma Treatment Market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decisionmaking process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: [email protected]
